[1]
Hasan, M.K. et al. 2026. Impact of Urinary NGAL in Predicting Response of β2 Microglobulin after Bortezomib Base Chemotherapy in Multiple Myeloma Patients. Bangladesh Renal Journal. 8, 1 (Mar. 2026), 16–23. DOI:https://doi.org/10.3329/brej.v8i1.88160.